400
Participants
Start Date
March 31, 2005
Study Completion Date
March 31, 2006
torcetrapib/atorvastatin
atorvastatin
Pfizer Investigational Site, Kopavogur
Pfizer Investigational Site, Camperdown
Pfizer Investigational Site, Clayton
Pfizer Investigational Site, Woolloongabba
Pfizer Investigational Site, North Adelaide
Pfizer Investigational Site, Perth
Pfizer Investigational Site, Parow
Pfizer Investigational Site, Bellville
Pfizer Investigational Site, Cape Town
Pfizer Investigational Site, Arhus C
Pfizer Investigational Site, Aalborg
Pfizer Investigational Site, Bloemfontein
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Dijon
Pfizer Investigational Site, Charlotte
Pfizer Investigational Site, Lutz
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Nantes
Pfizer Investigational Site, Indianapolis
Pfizer Investigational Site, Iowa City
Pfizer Investigational Site, Madison
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Houston
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Tripler AMC
Pfizer Investigational Site, Auburn
Pfizer Investigational Site, Scarborough
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Darlinghurst
Pfizer Investigational Site, Chicoutimi
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Ste-Foy
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Gothenburg
Pfizer Investigational Site, Linköping
Pfizer Investigational Site, Malmo
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site
Lead Sponsor
Pfizer
INDUSTRY